JPS58500562A - - Google Patents

Info

Publication number
JPS58500562A
JPS58500562A JP57501254A JP50125482A JPS58500562A JP S58500562 A JPS58500562 A JP S58500562A JP 57501254 A JP57501254 A JP 57501254A JP 50125482 A JP50125482 A JP 50125482A JP S58500562 A JPS58500562 A JP S58500562A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57501254A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US06/241,413 priority Critical patent/US4428883A/en
Application filed filed Critical
Publication of JPS58500562A publication Critical patent/JPS58500562A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
JP57501254A 1981-03-06 1982-03-05 Pending JPS58500562A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/241,413 US4428883A (en) 1981-03-06 1981-03-06 Novel method of administering β-blockers and novel dosage forms containing same

Publications (1)

Publication Number Publication Date
JPS58500562A true JPS58500562A (ja) 1983-04-14

Family

ID=22910593

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57501254A Pending JPS58500562A (ja) 1981-03-06 1982-03-05

Country Status (7)

Country Link
US (1) US4428883A (ja)
EP (1) EP0073819B1 (ja)
JP (1) JPS58500562A (ja)
AU (1) AU551567B2 (ja)
CA (1) CA1175747A (ja)
DE (1) DE3276410D1 (ja)
WO (1) WO1982003009A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03501390A (ja) * 1988-09-16 1991-03-28
JPH08500329A (ja) * 1992-03-13 1996-01-16 リボジーン,インコーポレーテッド 偏頭痛の治療
USRE36744E (en) * 1988-09-16 2000-06-20 Ribogene, Inc. Nasal administration of benzodiazepine hypnotics

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0570610B2 (ja) * 1984-10-26 1993-10-05 Nitto Denko Corp
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
US4681899A (en) * 1985-03-29 1987-07-21 Ohnishi S Tsuyoshi Method of preventing the growth of malaria parasites in erythrocytes
JPH01501708A (ja) * 1987-01-08 1989-06-15
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab NEW PHARMACEUTICAL PREPARATION
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.
SE464275B (sv) * 1989-07-31 1991-04-08 Aagerup Bengt NEW USE OF BETA-RECEPTOR BLOCKER FOR PREPARING A PREPARATION FOR MENIER'S DISEASE
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
BE1005615A3 (fr) * 1992-03-13 1993-11-23 Synepos Ag Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
US5498636A (en) * 1992-03-13 1996-03-12 Ribogene, Inc. Treatment of angina pectoris
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US5776930A (en) * 1996-06-28 1998-07-07 Merck & Company, Inc. Pharmaceutical preparation
WO2006039491A1 (en) * 2004-10-01 2006-04-13 Reliant Pharmaceuticals, Inc. Treating morning migraines with propanolol

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
US4161530A (en) * 1975-01-06 1979-07-17 Ciba-Geigy Corporation Pharmaceutical combination preparations as hypnotics
US4238485A (en) * 1979-10-29 1980-12-09 Merck & Co., Inc. Novel pharmaceutical compositions
EP0023704A2 (en) * 1979-08-03 1981-02-11 The University of Kentucky Research Foundation Novel dosage forms containing propanolol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB979389A (en) * 1962-01-29 1965-01-01 Ici Ltd Pharmaceutical compositions containing naphthalene derivatives
US4083992A (en) * 1972-12-15 1978-04-11 Imperial Chemical Industries Limited Alkanolamine derivatives
US3910988A (en) * 1973-10-23 1975-10-07 Abbott Lab Esters of {65 -glutamyl amide of dopamine
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4313956A (en) * 1979-12-28 1982-02-02 Interx Research Corp. Novel sypathomimetic amine prodrugs

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
US4161530A (en) * 1975-01-06 1979-07-17 Ciba-Geigy Corporation Pharmaceutical combination preparations as hypnotics
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
EP0023704A2 (en) * 1979-08-03 1981-02-11 The University of Kentucky Research Foundation Novel dosage forms containing propanolol
JPS5649313A (en) * 1979-08-03 1981-05-02 Uni Kentatsukii Research Fuand Propranolol novel dosage
US4238485A (en) * 1979-10-29 1980-12-09 Merck & Co., Inc. Novel pharmaceutical compositions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03501390A (ja) * 1988-09-16 1991-03-28
USRE36744E (en) * 1988-09-16 2000-06-20 Ribogene, Inc. Nasal administration of benzodiazepine hypnotics
JPH08500329A (ja) * 1992-03-13 1996-01-16 リボジーン,インコーポレーテッド 偏頭痛の治療

Also Published As

Publication number Publication date
AU551567B2 (en) 1986-05-01
DE3276410D1 (en) 1987-07-02
US4428883A (en) 1984-01-31
EP0073819A1 (en) 1983-03-16
AU8336982A (en) 1982-09-28
CA1175747A (en) 1984-10-09
WO1982003009A1 (en) 1982-09-16
CA1175747A1 (ja)
EP0073819A4 (en) 1984-11-16
EP0073819B1 (en) 1987-05-27

Similar Documents

Publication Publication Date Title
FR2498450B1 (ja)
JPH0136839B2 (ja)
GR76826B (ja)
IN152949B (ja)
JPS6365229B2 (ja)
JPS6117187B2 (ja)
JPH0322369B2 (ja)
JPS6367446B1 (ja)
DE3224415C2 (ja)
JPH0342199B2 (ja)
JPS6339812B2 (ja)
JPS642819B2 (ja)
FR2503569B1 (ja)
DE3226501C2 (ja)
JPH0316231B2 (ja)
JPS6146039B2 (ja)
JPS59500014A (ja)
JPH0158817B2 (ja)
JPH0242055B2 (ja)
JPH0240560B2 (ja)
FR2501579B1 (ja)
JPS6262335B2 (ja)
FR2518879B3 (ja)
JPH0242199B2 (ja)
FR2509989B1 (ja)